NYSE:LH - Laboratory Corp. of America Stock Price, Price Target & More

$172.71 +6.63 (+3.99 %)
(As of 04/25/2018 04:00 PM ET)
Previous Close$166.08
Today's Range$161.12 - $174.04
52-Week Range$136.61 - $181.71
Volume1.52 million shs
Average Volume690,451 shs
Market Capitalization$16.98 billion
P/E Ratio18.04
Dividend YieldN/A
Beta0.94

About Laboratory Corp. of America (NYSE:LH)

Laboratory Corp. of America logoLaboratory Corporation of America Holdings is a life sciences company that is integrated in guiding patient care, providing clinical laboratory and end-to-end drug development services. The Company operates as a healthcare diagnostics company. The Company operates through two segments: LabCorp Diagnostics (LCD) and Covance Drug Development (CDD). The LCD segment is an independent clinical laboratory business, which offers menu of frequently requested and specialty testing through an integrated network of primary and specialty laboratories across the United States. The CDD segment offers drug development services, and provides a range of drug research and development (R&D) and market access services to biopharmaceutical companies and medical device companies across the world. It serves a range of customers, including managed care organizations (MCOs), biopharmaceutical companies, governmental agencies, physicians and other healthcare providers.

Receive LH News and Ratings via Email

Sign-up to receive the latest news and ratings for LH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical laboratories
Sub-IndustryHealth Care Services
SectorMedical
SymbolNYSE:LH
CUSIP50540R40
Phone336-229-1127

Debt

Debt-to-Equity Ratio0.93%
Current Ratio1.31%
Quick Ratio1.20%

Price-To-Earnings

Trailing P/E Ratio18.04
Forward P/E Ratio14.95
P/E Growth1.42

Sales & Book Value

Annual Sales$10.44 billion
Price / Sales1.69
Cash Flow$15.5875 per share
Price / Cash11.08
Book Value$67.09 per share
Price / Book2.57

Profitability

EPS (Most Recent Fiscal Year)$9.60
Net Income$1.27 billion
Net Margins12.15%
Return on Equity16.30%
Return on Assets6.38%

Miscellaneous

Employees60,000
Outstanding Shares101,900,000

How to Become a New Pot Stock Millionaire

Laboratory Corp. of America (NYSE:LH) Frequently Asked Questions

What is Laboratory Corp. of America's stock symbol?

Laboratory Corp. of America trades on the New York Stock Exchange (NYSE) under the ticker symbol "LH."

How were Laboratory Corp. of America's earnings last quarter?

Laboratory Corp. of America Holdings (NYSE:LH) issued its quarterly earnings results on Wednesday, April, 25th. The medical research company reported $2.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.63 by $0.15. The medical research company had revenue of $2.85 billion for the quarter, compared to analyst estimates of $2.77 billion. Laboratory Corp. of America had a net margin of 12.15% and a return on equity of 16.30%. The company's revenue was up 18.0% compared to the same quarter last year. During the same period in the previous year, the business earned $2.22 EPS. View Laboratory Corp. of America's Earnings History.

When is Laboratory Corp. of America's next earnings date?

Laboratory Corp. of America is scheduled to release their next quarterly earnings announcement on Wednesday, April, 25th 2018. View Earnings Estimates for Laboratory Corp. of America.

What guidance has Laboratory Corp. of America issued on next quarter's earnings?

Laboratory Corp. of America updated its FY18 earnings guidance on Wednesday, April, 25th. The company provided earnings per share (EPS) guidance of $11.30-11.70 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $11.54.

What price target have analysts set for LH?

16 brokerages have issued 1 year price objectives for Laboratory Corp. of America's stock. Their predictions range from $172.00 to $210.00. On average, they expect Laboratory Corp. of America's stock price to reach $189.1333 in the next twelve months. View Analyst Ratings for Laboratory Corp. of America.

Who are some of Laboratory Corp. of America's key competitors?

Who are Laboratory Corp. of America's key executives?

Laboratory Corp. of America's management team includes the folowing people:
  • David P. King, Chairman of the Board, President, Chief Executive Officer (Age 61)
  • Glenn A. Eisenberg, Chief Financial Officer, Executive Vice President
  • John D. Ratliff, Chief Executive Officer - Covance Drug Development (Age 57)
  • Lisa J. Uthgenannt, Chief Human Resource Officer (Age 56)
  • Edward T. Dodson, Senior Vice President, Chief Accounting Officer, Principal Accounting Officer (Age 63)
  • Lance V. Berberian, Senior Vice President, Chief Information Officer (Age 54)
  • F. Samuel Eberts III, Senior Vice President, Chief Compliance Officer, Secretary, Chief Legal Officer (Age 57)
  • Robert E. Mittelstaedt Jr., Lead Independent Director (Age 73)
  • Kerrii B. Anderson, Independent Director (Age 60)
  • Jean-Luc Belingard, Independent Director (Age 68)

Has Laboratory Corp. of America been receiving favorable news coverage?

News headlines about LH stock have trended somewhat positive this week, Accern Sentiment Analysis reports. Accern identifies negative and positive press coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Laboratory Corp. of America earned a media sentiment score of 0.05 on Accern's scale. They also gave media headlines about the medical research company an impact score of 47.60 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.

How do I buy shares of Laboratory Corp. of America?

Shares of LH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Laboratory Corp. of America's stock price today?

One share of LH stock can currently be purchased for approximately $172.71.

How big of a company is Laboratory Corp. of America?

Laboratory Corp. of America has a market capitalization of $16.98 billion and generates $10.44 billion in revenue each year. The medical research company earns $1.27 billion in net income (profit) each year or $9.60 on an earnings per share basis. Laboratory Corp. of America employs 60,000 workers across the globe.

How can I contact Laboratory Corp. of America?

Laboratory Corp. of America's mailing address is 358 South Main Street, BURLINGTON NC, 27215. The medical research company can be reached via phone at 336-229-1127 or via email at [email protected]


MarketBeat Community Rating for Laboratory Corp. of America (LH)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  352 (Vote Outperform)
Underperform Votes:  396 (Vote Underperform)
Total Votes:  748
MarketBeat's community ratings are surveys of what our community members think about Laboratory Corp. of America and other stocks. Vote "Outperform" if you believe LH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LH will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Laboratory Corp. of America (NYSE:LH) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
16 Wall Street analysts have issued ratings and price targets for Laboratory Corp. of America in the last 12 months. Their average twelve-month price target is $189.1333, suggesting that the stock has a possible upside of 9.51%. The high price target for LH is $210.00 and the low price target for LH is $172.00. There are currently 5 hold ratings, 10 buy ratings and 1 strong buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.752.752.622.58
Ratings Breakdown: 0 Sell Rating(s)
5 Hold Rating(s)
10 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
10 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $189.1333$189.1333$172.9167$168.9091
Price Target Upside: 9.51% upside14.14% upside1.63% downside10.12% upside

Laboratory Corp. of America (NYSE:LH) Consensus Price Target History

Price Target History for Laboratory Corp. of America (NYSE:LH)

Laboratory Corp. of America (NYSE:LH) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/23/2018ArgusInitiated CoverageBuy$202.00HighView Rating Details
3/8/2018Credit Suisse GroupReiterated RatingOutperform -> Outperform$192.00 -> $195.00LowView Rating Details
3/6/2018Jefferies GroupReiterated RatingHold$176.00MediumView Rating Details
2/28/2018Morgan StanleyBoost Price TargetOverweight -> Overweight$182.00 -> $192.00MediumView Rating Details
2/28/2018Canaccord GenuityBoost Price TargetBuy -> Buy$190.00 -> $195.00MediumView Rating Details
2/26/2018BarclaysBoost Price TargetOverweight -> Overweight$195.00 -> $210.00MediumView Rating Details
2/9/2018CitigroupBoost Price TargetNeutral -> Neutral$161.00 -> $184.00MediumView Rating Details
2/8/2018Robert W. BairdSet Price TargetNeutral -> Hold$150.00 -> $183.00HighView Rating Details
2/7/2018Craig HallumReiterated RatingBuy$180.00 -> $204.00LowView Rating Details
1/29/2018Goldman SachsInitiated CoverageNeutral -> Buy$128.00 -> $205.00LowView Rating Details
1/24/2018MizuhoSet Price TargetHold$178.00LowView Rating Details
1/4/2018Evercore ISIInitiated CoverageOutperform -> Outperform$176.00HighView Rating Details
10/26/2017Deutsche BankBoost Price TargetBuy$170.00 -> $172.00N/AView Rating Details
10/12/2017SunTrust BanksReiterated RatingBuy$190.00N/AView Rating Details
10/12/2017Wells FargoInitiated CoverageMarket Perform -> Outperform$175.00N/AView Rating Details
9/26/2017KeyCorpReiterated RatingHoldLowView Rating Details
10/25/2016GabelliInitiated CoverageBuy$180.00N/AView Rating Details
7/28/2016UBSBoost Price TargetNeutral$125.00 -> $137.50N/AView Rating Details
(Data available from 4/25/2016 forward)

Earnings

Laboratory Corp. of America (NYSE:LH) Earnings History and Estimates Chart

Earnings by Quarter for Laboratory Corp. of America (NYSE:LH)

Laboratory Corp. of America (NYSE:LH) Earnings Estimates

2018 EPS Consensus Estimate: $11.07
2019 EPS Consensus Estimate: $12.43
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20185$2.34$2.75$2.52
Q2 20185$2.63$2.98$2.82
Q3 20185$2.66$2.99$2.87
Q4 20185$2.56$3.07$2.85
Q1 20192$2.76$2.89$2.83
Q2 20192$3.17$3.22$3.20
Q3 20192$3.22$3.23$3.23
Q4 20192$3.08$3.28$3.18

Laboratory Corp. of America (NYSE LH) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/25/2018Q1 2018$2.63$2.78$2.7742 billion$2.8480 billionViewN/AView Earnings Details
2/6/2018Q4 2017$2.38$2.45$2.6985 billion$2.7015 billionViewListenView Earnings Details
10/25/2017Q3 2017$2.38$2.46$2.5545 billion$2.5970 billionViewN/AView Earnings Details
7/26/2017Q2 2017$2.40$2.47$2.4672 billion$2.4984 billionViewN/AView Earnings Details
4/25/2017Q1 2017$2.19$2.22$2.4090 billion$2.4081 billionViewN/AView Earnings Details
2/16/2017Q416$2.13$2.15$2.35 billion$2.39 billionViewListenView Earnings Details
10/26/2016Q316$2.29$2.25$2.38 billion$2.40 billionViewListenView Earnings Details
7/27/2016Q216$2.30$2.31$2.33 billion$2.40 billionViewListenView Earnings Details
4/25/2016Q116$1.96$2.02$2.19 billion$2.30 billionViewListenView Earnings Details
2/18/2016Q415$1.99$1.98$2.22 billion$2.24 billionViewListenView Earnings Details
10/26/2015Q315$2.07$2.07$2.25 billion$2.30 billionViewListenView Earnings Details
7/28/2015Q215$2.03$2.09$2.22 billion$2.20 billionViewListenView Earnings Details
4/27/2015Q115$1.63$1.73$1.79 billion$1.80 billionViewListenView Earnings Details
2/20/2015Q4$1.63$1.65$1.4941 billion$1.5127 billionViewListenView Earnings Details
10/28/2014Q3$1.75$1.80$1.56 billion$1.55 billionViewListenView Earnings Details
7/18/2014Q214$1.77$1.84$1.50 billion$1.52 billionViewN/AView Earnings Details
4/28/2014Q114$1.58$1.51$1.45 billion$1.43 billionViewListenView Earnings Details
2/7/2014Q413$1.66$1.61$1.46 billion$1.44 billionViewListenView Earnings Details
10/18/2013Q313$1.80$1.80$1.45 billion$1.46 billionViewListenView Earnings Details
7/19/2013Q2 2013$1.80$1.80$1.46 billion$1.47 billionViewListenView Earnings Details
4/19/2013Q1 2013$1.77$1.74$1.4489 billion$1.4410 billionViewListenView Earnings Details
2/8/2013Q4 2012$1.62$1.54$1.39 billion$1.41 billionViewListenView Earnings Details
10/18/2012$1.74$1.76ViewN/AView Earnings Details
7/19/2012$1.76$1.77ViewN/AView Earnings Details
4/19/2012$1.67$1.74ViewN/AView Earnings Details
2/10/2012$1.41$1.46ViewN/AView Earnings Details
10/20/2011$1.50$1.61ViewN/AView Earnings Details
7/21/2011$1.53$1.64ViewN/AView Earnings Details
4/21/2011$1.46$1.52ViewN/AView Earnings Details
2/10/2011$1.31$1.34ViewN/AView Earnings Details
10/21/2010Q3 2010$1.40$1.47ViewN/AView Earnings Details
7/22/2010Q2 2010$1.42$1.46ViewN/AView Earnings Details
4/21/2010Q1 2010$1.31$1.30ViewN/AView Earnings Details
2/11/2010Q4 2009$1.15$1.16ViewN/AView Earnings Details
10/22/2009Q3 2009$1.15$1.22ViewN/AView Earnings Details
7/23/2009Q2 2009$1.27$1.30ViewN/AView Earnings Details
4/23/2009Q1 2009$1.17$1.22ViewN/AView Earnings Details
2/12/2009Q4 2008$1.09$1.10ViewN/AView Earnings Details
10/23/2008Q3 2008$1.12$1.13ViewN/AView Earnings Details
7/24/2008Q2 2008$1.24$1.24ViewN/AView Earnings Details
4/24/2008Q1 2008$1.14$1.14ViewN/AView Earnings Details
2/7/2008Q4 2007$1.00$1.04ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Laboratory Corp. of America (NYSE:LH) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Laboratory Corp. of America (NYSE LH) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.73%
Institutional Ownership Percentage: 92.67%
Insider Trading History for Laboratory Corp. of America (NYSE:LH)
Insider Trading History for Laboratory Corp. of America (NYSE:LH)

Laboratory Corp. of America (NYSE LH) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/23/2018David P KingCEOSell49,967$164.75$8,232,063.25231,202View SEC Filing  
2/12/2018Glenn A EisenbergCFOSell8,400$167.36$1,405,824.0015,931View SEC Filing  
2/8/2018Adam H SchechterDirectorSell1,263$169.29$213,813.277,297View SEC Filing  
10/30/2017Dwight Gary GillilandDirectorSell971$153.52$149,067.923,501View SEC Filing  
9/6/2017David P KingCEOSell44,687$156.86$7,009,602.82258,753View SEC Filing  
9/5/2017David P. KingCEOSell132,713$157.06$20,843,903.78View SEC Filing  
8/25/2017F Samuel Eberts IIIInsiderSell31,500$155.22$4,889,430.0031,894View SEC Filing  
8/11/2017R Sanders WilliamsDirectorSell3,100$156.88$486,328.0010,073View SEC Filing  
8/1/2017Glenn A EisenbergCFOSell5,968$159.46$951,657.2818,122View SEC Filing  
8/1/2017Lisa J. UthgenanntInsiderSell5,000$160.00$800,000.00View SEC Filing  
5/22/2017Lance BerberianSVPSell3,613$139.84$505,241.925,789View SEC Filing  
5/9/2017Jean-Luc BelingardDirectorSell992$142.19$141,052.4832,935View SEC Filing  
3/9/2017Glenn A EisenbergCFOSell2,300$142.47$327,681.0012,556View SEC Filing  
2/24/2017Robert E Mittelstaedt JrDirectorSell5,300$142.69$756,257.0018,208View SEC Filing  
8/9/2016Lisa J UthgenanntInsiderSell1,177$140.00$164,780.003,660View SEC Filing  
8/4/2016Glenn A EisenbergCFOSell8,000$140.10$1,120,800.008,668View SEC Filing  
8/4/2016Robert E Mittelstaedt JrDirectorSell992$140.15$139,028.8012,340View SEC Filing  
6/13/2016David P KingCEOSell196,400$128.00$25,139,200.00271,210View SEC Filing  
4/27/2016Edward T DodsonInsiderSell9,392$126.42$1,187,336.642,717View SEC Filing  
3/31/2016F Samuel Eberts IIIInsiderSell4,219$116.85$492,990.1524,751View SEC Filing  
3/31/2016James T Jr. BoyleCEOSell18,132$116.81$2,117,998.9258,191View SEC Filing  
3/14/2016F Samuel Eberts IIIInsiderSell309$115.32$35,633.8818,529View SEC Filing  
3/14/2016James T Jr. BoyleCEOSell1,543$115.32$177,938.7626,410View SEC Filing  
2/25/2016Jean-Luc BelingardDirectorSell1,296$109.74$142,223.0430,722View SEC Filing  
2/16/2016F Samuel Eberts IIIInsiderSell370$103.02$38,117.4018,066View SEC Filing  
2/16/2016James T. Jr. BoyleCEOSell4,055$103.02$417,746.1023,454View SEC Filing  
2/12/2016F Samuel Eberts IIIinsiderSell405$101.67$41,176.3518,436View SEC Filing  
2/12/2016James T. Jr. BoyleCEOSell2,712$101.67$275,729.0427,509View SEC Filing  
1/8/2016F Samuel Eberts IIIInsiderSell1,215$119.05$144,645.7518,066View SEC Filing  
12/8/2015F Samuel Eberts IIIInsiderSell1,010$123.31$124,543.1019,281View SEC Filing  
11/2/2015R Sanders WilliamsDirectorSell1,850$124.30$229,955.004,176View SEC Filing  
7/1/2015David P KingCEOSell50,000$121.78$6,089,000.00View SEC Filing  
4/29/2015Jean-Luc BelingardDirectorSell1,542$123.10$189,820.20View SEC Filing  
4/23/2015James T Jr. BoyleCEOSell1,394$126.56$176,424.64View SEC Filing  
3/31/2015Mark E BrecherCMOSell20,625$126.98$2,618,962.50View SEC Filing  
3/30/2015Mark E BrecherCMOSell20,278$126.98$2,574,900.44View SEC Filing  
3/3/2015James T Jr. BoyleCOOSell1,237$123.70$153,016.90View SEC Filing  
2/13/2015James T Jr. BoyleCOOSell6,597$116.68$769,737.96View SEC Filing  
9/22/2014David P KingCEOSell65,234$104.71$6,830,652.14View SEC Filing  
9/5/2014R Sanders WilliamsDirectorSell2,000$107.95$215,900.00View SEC Filing  
8/22/2014David P KingCEOSell65,233$106.10$6,921,221.30View SEC Filing  
7/22/2014David P KingCEOSell65,233$105.55$6,885,343.15View SEC Filing  
6/9/2014James T Jr. BoyleCOOSell38,600$103.00$3,975,800.00View SEC Filing  
5/7/2014M Keith WeikelDirectorSell1,984$98.28$194,987.5213,958View SEC Filing  
3/28/2014James Jr. BoyleCOOSell2,521$98.36$247,965.5625,821View SEC Filing  
3/7/2014William HayesCFOSell23,848$94.40$2,251,251.2019,400View SEC Filing  
2/13/2014James Jr. BoyleCOOSell4,123$90.29$372,265.6728,188View SEC Filing  
2/11/2014James Jr. BoyleCOOSell1,204$91.15$109,744.6028,188View SEC Filing  
1/27/2014David KingCEOSell24,200$90.15$2,181,630.0063,699View SEC Filing  
12/24/2013David KingCEOSell25,000$90.79$2,269,750.0063,628View SEC Filing  
10/24/2013David P KingCEOSell25,000$100.91$2,522,750.00View SEC Filing  
10/17/2013James T Jr. BoyleCOOSell24,400$102.00$2,488,800.00View SEC Filing  
9/25/2013David KingCEOSell25,000$99.06$2,476,500.0063,628View SEC Filing  
8/26/2013David KingCEOSell25,000$96.60$2,415,000.0063,628View SEC Filing  
8/21/2013Robert Mittelstaedt, Jr.DirectorSell7,429$96.86$719,572.947,015View SEC Filing  
7/24/2013David P KingCEOSell25,000$97.72$2,443,000.00View SEC Filing  
6/24/2013David P KingCEOSell25,000$98.66$2,466,500.00View SEC Filing  
6/7/2013James T Jr. BoyleCOOSell63,100$99.63$6,286,653.00View SEC Filing  
5/28/2013Mark E BrecherInsiderSell16,900$100.92$1,705,548.00View SEC Filing  
5/21/2013William B HayesCFOSell127,200$100.00$12,720,000.00View SEC Filing  
5/17/2013F Samuel Eberts IIIInsiderSell10,000$98.47$984,700.00View SEC Filing  
5/10/2013James T Jr. BoyleCOOSell68,908$93.82$6,464,948.56View SEC Filing  
5/8/2013Jean-Luc BelingardDirectorSell2,536$92.88$235,543.68View SEC Filing  
4/11/2013William B HayesCFOSell22,234$95.00$2,112,230.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Laboratory Corp. of America (NYSE LH) News Headlines

Source:
DateHeadline
Laboratory of America Holdings (LH) Q1 2018 Results - Earnings Call TranscriptLaboratory of America Holdings (LH) Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - April 25 at 4:45 PM
Laboratory Corp. of America (LH) Issues Quarterly  Earnings ResultsLaboratory Corp. of America (LH) Issues Quarterly Earnings Results
www.americanbankingnews.com - April 25 at 11:23 AM
Laboratory Corp. of America (LH) Updates FY18 Earnings GuidanceLaboratory Corp. of America (LH) Updates FY18 Earnings Guidance
www.americanbankingnews.com - April 25 at 9:50 AM
Laboratory Corporation Of America Holdings Q1 adjusted earnings of $2.78 per shareLaboratory Corporation Of America Holdings Q1 adjusted earnings of $2.78 per share
www.nasdaq.com - April 25 at 9:20 AM
LabCorp: 1Q Earnings SnapshotLabCorp: 1Q Earnings Snapshot
finance.yahoo.com - April 25 at 9:20 AM
LabCorp quarterly profit falls 5.4 pctLabCorp quarterly profit falls 5.4 pct
finance.yahoo.com - April 25 at 9:20 AM
LabCorp quarterly profit beats estimatesLabCorp quarterly profit beats estimates
finance.yahoo.com - April 25 at 9:20 AM
LabCorp and Mount Sinai Health System Enhance Laboratory Operations to Improve Patient CareLabCorp and Mount Sinai Health System Enhance Laboratory Operations to Improve Patient Care
finance.yahoo.com - April 24 at 9:14 AM
Walgreens to add LabCorp patient centers in 10 Florida stores, including OrlandoWalgreens to add LabCorp patient centers in 10 Florida stores, including Orlando
finance.yahoo.com - April 23 at 4:34 PM
LabCorp at Walgreens Expands into FloridaLabCorp at Walgreens Expands into Florida
finance.yahoo.com - April 23 at 9:01 AM
Stock Traders Buy Large Volume of Laboratory Corp. of America Put Options (LH)Stock Traders Buy Large Volume of Laboratory Corp. of America Put Options (LH)
www.americanbankingnews.com - April 20 at 7:09 AM
Credit Suisse Group Lowers Laboratory Corp. of America (LH) to HoldCredit Suisse Group Lowers Laboratory Corp. of America (LH) to Hold
www.americanbankingnews.com - April 18 at 2:58 PM
Laboratory Corp. of America (LH) Set to Announce Quarterly Earnings on WednesdayLaboratory Corp. of America (LH) Set to Announce Quarterly Earnings on Wednesday
www.americanbankingnews.com - April 18 at 3:10 AM
Can LaunchPad Aid LabCorp's (LH) Covance Arm in Q1 Earnings?Can LaunchPad Aid LabCorp's (LH) Covance Arm in Q1 Earnings?
finance.yahoo.com - April 17 at 5:03 PM
Laboratory Corp. of America (LH) Upgraded at Zacks Investment ResearchLaboratory Corp. of America (LH) Upgraded at Zacks Investment Research
www.americanbankingnews.com - April 15 at 2:53 PM
Laboratory Corp. of America (LH) Price Target Raised to $183.00 at BarclaysLaboratory Corp. of America (LH) Price Target Raised to $183.00 at Barclays
www.americanbankingnews.com - April 15 at 12:01 PM
 Brokerages Expect Laboratory Corp. of America Holdings (LH) Will Post Quarterly Sales of $2.77 Billion Brokerages Expect Laboratory Corp. of America Holdings (LH) Will Post Quarterly Sales of $2.77 Billion
www.americanbankingnews.com - April 13 at 4:31 AM
Hitachi High-Tech Participates in OmniSeq Series B and Secures Japanese Distribution RightsHitachi High-Tech Participates in OmniSeq Series B and Secures Japanese Distribution Rights
finance.yahoo.com - April 12 at 10:07 AM
 Analysts Expect Laboratory Corp. of America Holdings (LH) Will Post Earnings of $2.65 Per Share Analysts Expect Laboratory Corp. of America Holdings (LH) Will Post Earnings of $2.65 Per Share
www.americanbankingnews.com - April 11 at 8:23 AM
LabCorp's RTP expansion to add 422 jobsLabCorp's RTP expansion to add 422 jobs
finance.yahoo.com - April 10 at 4:38 PM
Updated: LabCorp plans to add more than 400 jobs as it expands in RTPUpdated: LabCorp plans to add more than 400 jobs as it expands in RTP
finance.yahoo.com - April 10 at 4:38 PM
ValuEngine Lowers Laboratory Corp. of America (LH) to HoldValuEngine Lowers Laboratory Corp. of America (LH) to Hold
www.americanbankingnews.com - April 8 at 7:34 PM
Laboratory Corp. of America (LH) Stock Rating Reaffirmed by Robert W. BairdLaboratory Corp. of America (LH) Stock Rating Reaffirmed by Robert W. Baird
www.americanbankingnews.com - April 6 at 11:35 PM
Laboratory Corp. of America Holdings (LH) Receives Consensus Recommendation of "Buy" from AnalystsLaboratory Corp. of America Holdings (LH) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - April 5 at 3:24 AM
Deutsche Bank Increases Laboratory Corp. of America (LH) Price Target to $172.00Deutsche Bank Increases Laboratory Corp. of America (LH) Price Target to $172.00
www.americanbankingnews.com - April 4 at 7:30 PM
Laboratory Corp. of America (LH) PT Raised to $190.00Laboratory Corp. of America (LH) PT Raised to $190.00
www.americanbankingnews.com - April 4 at 6:23 PM
Compensation climbs for LabCorp CEO, slips for CFOCompensation climbs for LabCorp CEO, slips for CFO
finance.yahoo.com - April 3 at 4:39 PM
Laboratory Corp. of America (LH) Downgraded by Zacks Investment Research to "Sell"Laboratory Corp. of America (LH) Downgraded by Zacks Investment Research to "Sell"
www.americanbankingnews.com - March 30 at 11:10 PM
Laboratory Corp. of America (LH) Upgraded to Hold by Zacks Investment ResearchLaboratory Corp. of America (LH) Upgraded to Hold by Zacks Investment Research
www.americanbankingnews.com - March 29 at 1:58 PM
Laboratory Corp. of America Holdings (LH) CEO David P. King Sells 49,967 SharesLaboratory Corp. of America Holdings (LH) CEO David P. King Sells 49,967 Shares
www.americanbankingnews.com - March 27 at 10:23 AM
LabCorp Forms Lab-Alliance With Kentucky-Based Health FirmLabCorp Forms Lab-Alliance With Kentucky-Based Health Firm
finance.yahoo.com - March 23 at 4:36 PM
Laboratory Corp. of America (LH) Coverage Initiated by Analysts at ArgusLaboratory Corp. of America (LH) Coverage Initiated by Analysts at Argus
www.americanbankingnews.com - March 23 at 4:00 PM
Is Laboratory Corporation (LH) a Great Stock for Value Investors?Is Laboratory Corporation (LH) a Great Stock for Value Investors?
www.zacks.com - March 23 at 9:16 AM
LabCorp forms lab partnership with Kentucky health systemLabCorp forms lab partnership with Kentucky health system
finance.yahoo.com - March 22 at 4:35 PM
LabCorp and Appalachian Regional Healthcare Create Comprehensive Laboratory CollaborationLabCorp and Appalachian Regional Healthcare Create Comprehensive Laboratory Collaboration
finance.yahoo.com - March 22 at 9:31 AM
LabCorp & Interpace Team Up, Drive Specialty DiagnosticsLabCorp & Interpace Team Up, Drive Specialty Diagnostics
finance.yahoo.com - March 21 at 4:41 PM
Analyzing HealthStream (HSTM) and Laboratory Corp. of America (LH)Analyzing HealthStream (HSTM) and Laboratory Corp. of America (LH)
www.americanbankingnews.com - March 17 at 3:06 AM
Rick Goldwasser - BenzingaRick Goldwasser - Benzinga
www.benzinga.com - March 14 at 5:55 PM
Morgan Stanley: Quest Diagnostics Has Balanced Risk-Reward - BenzingaMorgan Stanley: Quest Diagnostics Has Balanced Risk-Reward - Benzinga
www.benzinga.com - March 14 at 5:55 PM
LabCorps Covance forms unit to focus on biologic drug developmentLabCorp's Covance forms unit to focus on biologic drug development
finance.yahoo.com - March 13 at 6:29 PM
3 Top Healthcare Stocks to Buy in March3 Top Healthcare Stocks to Buy in March
finance.yahoo.com - March 12 at 5:39 PM
Laboratory Corp. of America Holdings (LH) Receives Average Recommendation of "Buy" from AnalystsLaboratory Corp. of America Holdings (LH) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - March 11 at 7:08 AM
Zacks: Brokerages Expect Laboratory Corp. of America Holdings (LH) Will Post Quarterly Sales of $2.76 BillionZacks: Brokerages Expect Laboratory Corp. of America Holdings (LH) Will Post Quarterly Sales of $2.76 Billion
www.americanbankingnews.com - March 10 at 11:23 AM
LabCorp to cut 195 jobs in SpokaneLabCorp to cut 195 jobs in Spokane
finance.yahoo.com - March 9 at 5:40 PM
Covance Forms Immunology & Immunotoxicology Unit Focused on Biologic Drug DevelopmentCovance Forms Immunology & Immunotoxicology Unit Focused on Biologic Drug Development
finance.yahoo.com - March 9 at 9:47 AM
Laboratory Corp. of America (LH) Given New $195.00 Price Target at Credit Suisse GroupLaboratory Corp. of America (LH) Given New $195.00 Price Target at Credit Suisse Group
www.americanbankingnews.com - March 8 at 6:41 PM
Laboratory Corporation of America (LH) Presents At Raymond James 39th Annual Institutional Investors Conference - SlideshowLaboratory Corporation of America (LH) Presents At Raymond James 39th Annual Institutional Investors Conference - Slideshow
seekingalpha.com - March 8 at 5:33 PM
LabCorp (LH) Up 1.1% Since Earnings Report: Can It Continue?LabCorp (LH) Up 1.1% Since Earnings Report: Can It Continue?
finance.yahoo.com - March 8 at 5:32 PM
Jefferies Group Weighs in on Laboratory Corp. of America Holdings Q1 2018 Earnings (LH)Jefferies Group Weighs in on Laboratory Corp. of America Holdings' Q1 2018 Earnings (LH)
www.americanbankingnews.com - March 8 at 6:28 AM
Zacks: Brokerages Expect Laboratory Corp. of America Holdings (LH) Will Post Earnings of $2.63 Per ShareZacks: Brokerages Expect Laboratory Corp. of America Holdings (LH) Will Post Earnings of $2.63 Per Share
www.americanbankingnews.com - March 8 at 1:08 AM

SEC Filings

Laboratory Corp. of America (NYSE:LH) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Laboratory Corp. of America (NYSE:LH) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Laboratory Corp. of America (NYSE LH) Stock Chart for Wednesday, April, 25, 2018

Loading chart…

This page was last updated on 4/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.